Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases. Boudinar F, Larbaoui B. Ann Oncol 2019;30 Suppl 4:iv41-iv42.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boudinar F, Larbaoui B. Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases. Ann Oncol 2019;30 Suppl 4:iv41-iv42.
PMID: 32085155